NOT YET RECRUITING
NCT07787130
Effect of Immune X on Common Cold Incidence in Healthy Adults
The goal of this clinical trial is to learn if Immune X can help prevent common cold events in healthy adults who have a history of upper respiratory tract infections. The main questions it aims to answer are:
* Does Immune X reduce the proportion of participants who experience at least one clinically confirmed common cold event during the study period?
* Does Immune X affect the number, duration, and severity of common cold events?
Researchers will compare Immune X to a placebo (a look-alike capsule containing inactive ingredients) to see if Immune X helps prevent common cold events.
Participants will:
* Take Immune X or placebo daily for 16 weeks during the winter season.
* Attend study visits at the beginning and end of the study and complete questionnaires and symptom assessments throughout the study.
* Record cold symptoms, medications, and other study information using a smartphone application.
* Provide blood and stool samples during the study.
Gender: All
Ages: 18 Years - 65 Years
Common Cold
Upper Respiratory Tract Infection (URTI)